Strategic Growth STARLIMS is expanding through acquisitions and AI initiatives, including agentic AI capabilities and the MODA Platform, signaling opportunities to upsell integrated LIMS/ELN solutions, AI-enhanced workflows, and manufacturing quality control modules to regulated labs and CDMOs.

Public Health Focus Launched STARLIMS Life Sciences for Public Health, highlighting demand for lab informatics in epidemiology, surveillance and public health testing, offering a route to government and large health networks with scalable, compliant data capture and analytics.

Strong Enterprise Footprint With over 2,000 labs, 1,100+ customers across 85 countries, STARLIMS demonstrates broad enterprise reach and referenceability, presenting cross-sell and expansion opportunities within existing accounts and in new regional markets.

Recent Leadership and AI New CEO and ongoing AI strategy indicate a focused push on automation and AI-enabled lab workflows, creating opportunities to position STARLIMS as the platform of choice for customers seeking accelerated ROI and advanced analytics in regulated environments.

Financial Readiness Significant revenue and a recent funding/strategic investment from Turn/River Capital imply strong capital backing for growth initiatives, enabling larger multi-site deployments, integrations, and long-term licensing deals with major pharma, biotech, and manufacturing customers.